ClinicalTrials.gg
CompletedNCT05422638RBSTEUpdated Dec 29, 2025Results posted

Race-Based Stress Trauma and Empowerment

An interventional study of RBSTE and PCT in Life Stress and Racism, sponsored by VA Office of Research and Development. Completed at 1 site in United States. Open to participants aged 18 Years and older, including healthy volunteers. Per ClinicalTrials.gov, last updated 2025-12-29.

Sponsored by VA Office of Research and Development · Not applicable, Interventional, and Other

Phase
Not applicable
Study type
Interventional
Enrollment
37
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The existence of racially/ethnically based health disparities is well established, both within the civilian community and among Service Members and Veterans. Experiences of discrimination are acute and chronic stressors that substantially contribute to greater emotional distress, poorer health behavior, lower healthcare utilization and increased allostatic load, all of which undermine well-being, functioning and Whole Health. An innovative clinical program, the Race-Based Stress/Trauma and Empowerment (RBSTE) group, was developed to help Veterans of Color to build coping resources and empowerment. Although qualitative data suggest the promise of this intervention, systematic evaluation is lacking. The proposed feasibility project will lay the groundwork for a future randomized controlled trial to evaluate RBSTE as compared to a control group in terms of Whole Health, functioning and mental/physical wellness. The project thus begins a program of research to address the health implications of systemic racism.

Read the detailed description

Health disparities between White and Black, Indigenous and People of Color (BIPOC) are well documented in the United States; this phenomenon is driven in part by discrimination experiences and is an important contributor to well-being and functioning, including among military service members and Veterans. The chronic stress of racism has both psychological and physiological effects. Discrimination is associated with increased psychological distress, including higher rates of PTSD among Veterans of Color (VOC), poorer health behavior and decreased healthcare utilization. Race-based stress is also linked to increased allostatic load (AL), which is a measurable index of wear-and-tear on the body due to chronic stress exposure that is associated with greater disease burden and mortality. Recognizing the unmet need for interventions to help VOC process and cope with experiences of discrimination, the Race-based Stress/Trauma and Empowerment (RBSTE) intervention (Carlson, Endsley, Motley, Shawahin, \& Williams, 2018) was developed. RBSTE is a group-based approach that combines cultural adaptations of established psychotherapeutic techniques with novel strategies to foster resilience and empowerment for VOC. Initial qualitative data suggests the promise of this approach, but no systematic data are yet available to determine whether or not RBSTE is achieving its goals of enhancing coping and restoring well-being. The proposed project is a pilot randomized controlled trial (RCT) with multi-modal longitudinal assessment. Participants will be recruited from VA facilities and the surrounding community. VOC who report race-based stress, with minimal exclusions, will be evaluated at baseline, randomized in groups to one of two wellness interventions and then re-evaluated immediately after treatment. The interventions include RBSTE and Present Centered Therapy (PCT), designed to control for nonspecific aspects of RBSTE, including support and participation in an all-BIPOC group. The interventions will be delivered in 8 weekly 90-minute group sessions by a trained mental health professional using videoconferencing. The aims of the project are (1) to assess the feasibility of recruiting VOC for an RCT of this nature; (2) to examine the acceptability and appropriateness of intervention content, the feasibility of participation, and participant's perceptions of provider behavior and attitudes; and (3) to establish the optimal strategy for quantifying mental and physical health outcomes for future studies. Thus, the project will set the stage for evaluation of RBSTE's efficacy and ultimately implementation. This critically important program of research will provide guidance as to best practices for the management of race-based stress, with the ultimate goal of eliminating health disparities for Veterans and the community more broadly.

02

Conditions studied

  • Life Stress
  • Racism

Keywords

  • Life stress
  • Racism
  • Health promotion
  • Randomized controlled trial
03

In context

Stress, Psychological

844 studies on the registry are indexed under Stress, Psychological; 136 are open to participants now.

This study's enrollment of 37 is below the median of 84 across 688 interventional studies indexed under Stress, Psychological.

Browse Stress, Psychological studies →

Lead sponsor

VA Office of Research and Development is the lead sponsor of 1,771 studies on the registry; 392 are open to participants now.

Of its 213 completed or terminated interventional studies of FDA-regulated products, 185 (87%) have results posted.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • self-identified as a BIPOC
  • Veteran
  • able to consent to study activities
  • endorsing one or more perceived discrimination experiences on the Everyday Discrimination Form (short version) or the Major Experiences of Discrimination Scale (abbreviated version) "a few times a year" or more frequently and endorsing stress on a validated single-item measure

Exclusion criteria

Exclusion Criteria:

  • serious mental illness, alcohol/substance use disorders, or cognitive impairment that may interfere with the ability to benefit from group

    • (e.g., severe depression, psychotic illness, mania, dementia, untreated alcohol/substance dependence)
  • serious suicidality or homicidality (e.g., ideation with plan/intent) that is likely to require urgent/emergent intervention within the study period
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
37 participants (actual)

Study arms

  • Experimental
    RBSTE

    8-week health promotion group focused on supporting coping with racism and empowerment

    Behavioral: RBSTE

  • Active comparator
    PCT

    8-week health promotion group focused on providing support and facilitating problem solving

    Behavioral: PCT

Interventions

  • BehavioralRBSTE

    8-week health promotion group focused on supporting coping with racism and empowerment

  • BehavioralPCT

    8-week health promotion group focused on providing support and facilitating problem solving

    Also known as: Present Centered Therapy

06

What researchers measure

Primary outcomes

  1. Enrollment Rate

    Percentage of individuals enrolled out of total contacted

    Time frame: week 0

  2. Initiation Rate

    Percentage of subjects who initiate any intervention among all enrolled subjects

    Time frame: week 1

  3. Per Protocol Completion

    Percentage of subjects who complete 5 or 6 sessions of intervention among those who start the intervention

    Time frame: week 8

  4. Intent-to-treat Completion

    Percentage of subjects who complete 5 or 6 sessions of intervention among all randomized subjects

    Time frame: week 8

  5. Acceptability of Intervention Measure (AIM)

    Perceived acceptability of the interventions by participants AIM range 4-20 with greater scores indicating better acceptability

    Time frame: week 8

  6. Intervention Appropriateness Measure (IAM)

    Perceived appropriateness of the interventions by participants IAM range 4-20 with greater scores indicating better appropriateness

    Time frame: week 8

  7. Feasibility of Intervention Measure (FIM)

    Perceived feasibility of the interventions by participants FIM range 4-20 with greater scores indicating better feasibility

    Time frame: week 8

Secondary outcomes

  1. Brief Personal Health Inventory (B-PHI): Physical Health

    self-appraisal of physical well being range 1-5 with higher scores indicating better health

    Time frame: change from week 1 to week 8

  2. Brief Personal Health Inventory (B-PHI): Mental Health

    self-appraisal of mental well being range 1-5 with higher scores indicating better mental health

    Time frame: change from week 1 to week 8

  3. Brief Personal Health Inventory (B-PHI): Daily Living

    self-appraisal of daily living range 1-5 with higher scores indicating better daily living

    Time frame: change from week 1 to week 8

07

Results

Posted Dec 29, 2025

Participant flow

Participant flow — Overall Study
MilestoneRace-Based Stress Trauma & Empowerment (RBSTE)Present-Centered Wellness Group (PCWG)
Started1918
Completed1116
Not completed82
Withdrew: Withdrawal by subject82

Outcome measures

PrimaryEnrollment Rate

Percentage of individuals enrolled out of total contacted

Time frame:
week 0
Reported as:
Number · percentage of individuals approached
Enrollment Rate
percentage of individuals approachedTotal Sample
Enrollment Rate8.87
PrimaryInitiation Rate

Percentage of subjects who initiate any intervention among all enrolled subjects

Time frame:
week 1
Reported as:
Number · percentage of enrolled individuals
Initiation Rate
percentage of enrolled individualsRBSTEPCWG
Initiation Rate73.7100
PrimaryPer Protocol Completion

Percentage of subjects who complete 5 or 6 sessions of intervention among those who start the intervention

Time frame:
week 8
Reported as:
Number · percent inititiators completed 5+
Per Protocol Completion
percent inititiators completed 5+RBSTEPCWG
Per Protocol Completion64.794.1
PrimaryIntent-to-treat Completion

Percentage of subjects who complete 5 or 6 sessions of intervention among all randomized subjects

Time frame:
week 8
Reported as:
Number · percentage of ITT completed 5+
Intent-to-treat Completion
percentage of ITT completed 5+RBSTEPCWG
Intent-to-treat Completion57.988.9
PrimaryAcceptability of Intervention Measure (AIM)

Perceived acceptability of the interventions by participants AIM range 4-20 with greater scores indicating better acceptability

Time frame:
week 8
Reported as:
Mean · total score on a scale
Acceptability of Intervention Measure (AIM)
total score on a scaleRace-Based Stress Trauma & Empowerment (RBSTE)Present-Centered Wellness Group (PCWG)
Acceptability of Intervention Measure (AIM)18.43 ± 1.8114.75 ± 3.84
PrimaryIntervention Appropriateness Measure (IAM)

Perceived appropriateness of the interventions by participants IAM range 4-20 with greater scores indicating better appropriateness

Time frame:
week 8
Reported as:
Mean · total score on a scale
Intervention Appropriateness Measure (IAM)
total score on a scaleRace-Based Stress Trauma & Empowerment (RBSTE)Present-Centered Wellness Group (PCWG)
Intervention Appropriateness Measure (IAM)17.57 ± 2.7014.25 ± 3.77
PrimaryFeasibility of Intervention Measure (FIM)

Perceived feasibility of the interventions by participants FIM range 4-20 with greater scores indicating better feasibility

Time frame:
week 8
Reported as:
Mean · total score on a scale
Feasibility of Intervention Measure (FIM)
total score on a scaleRace-Based Stress Trauma & Empowerment (RBSTE)Present-Centered Wellness Group (PCWG)
Feasibility of Intervention Measure (FIM)17.43 ± 2.2214.88 ± 3.52
SecondaryBrief Personal Health Inventory (B-PHI): Physical Health

self-appraisal of physical well being range 1-5 with higher scores indicating better health

Time frame:
change from week 1 to week 8
Reported as:
Mean · change score on a scale
Brief Personal Health Inventory (B-PHI): Physical Health
change score on a scaleRace-Based Stress Trauma & Empowerment (RBSTE)Present-Centered Wellness Group (PCWG)
Brief Personal Health Inventory (B-PHI): Physical Health0.1 ± 0.880.27 ± 0.53
SecondaryBrief Personal Health Inventory (B-PHI): Mental Health

self-appraisal of mental well being range 1-5 with higher scores indicating better mental health

Time frame:
change from week 1 to week 8
Reported as:
Mean · change in score on a scale
Brief Personal Health Inventory (B-PHI): Mental Health
change in score on a scaleRace-Based Stress Trauma & Empowerment (RBSTE)Present-Centered Wellness Group (PCWG)
Brief Personal Health Inventory (B-PHI): Mental Health0.97 ± 1.140.61 ± 0.76
SecondaryBrief Personal Health Inventory (B-PHI): Daily Living

self-appraisal of daily living range 1-5 with higher scores indicating better daily living

Time frame:
change from week 1 to week 8
Reported as:
Mean · change in score on a scale
Brief Personal Health Inventory (B-PHI): Daily Living
change in score on a scaleRace-Based Stress Trauma & Empowerment (RBSTE)Present-Centered Wellness Group (PCWG)
Brief Personal Health Inventory (B-PHI): Daily Living1.07 ± 0.990.43 ± 0.93

Adverse events

Collected over 8 weeks. Non-serious events are listed at a 0% frequency threshold.

Adverse event summary by group
GroupDeathsSeriousOther
Race-Based Stress Trauma & Empowerment (RBSTE)0/19 (0%)0/19 (0%)0/19 (0%)
Present-Centered Wellness Group (PCWG)0/18 (0%)0/18 (0%)0/18 (0%)

Baseline characteristics

Age, Continuous
Age, Continuous(years)RBSTEPCWGTotal
Mean56.2 ± 1746.9 ± 14.649.9 ± 16.2
Sex: Female, Male
Sex: Female, Male(Participants)RBSTEPCWGTotal
Female6612
Male131225
Ethnicity (NIH/OMB)
Ethnicity (NIH/OMB)(Participants)RBSTEPCWGTotal
Hispanic or Latino5611
Not Hispanic or Latino131225
Unknown or Not Reported101
Race (NIH/OMB)
Race (NIH/OMB)(Participants)RBSTEPCWGTotal
American Indian or Alaska Native101
Asian011
Native Hawaiian or Other Pacific Islander000
Black or African American121224
White459
More than one race101
Unknown or Not Reported101
Region of Enrollment
Region of Enrollment(participants)RBSTEPCWGTotal
United States191837
08

Study locations

1 site
  • VA San Diego Healthcare System, San Diego, CA
    San Diego, California 92161-0002, United States
09

References and documents

Publications

  • Wang C, Malaktaris A, McLean CL, Kelsven S, Chu GM, Ross KS, Endsley M Jr, Minassian A, Liu L, Hong S, Lang AJ. Mitigating the health effects of systemic racism: Evaluation of the Race-Based Stress and Trauma Empowerment intervention. Contemp Clin Trials. 2023 Apr;127:107118. doi: 10.1016/j.cct.2023.107118. Epub 2023 Feb 14. PubMed 36796623 ↗

Study documents

PDFs hosted by the registry, ClinicalTrials.gov.

Individual participant data

Plan to share: No

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Jan 2023 to primary completion in Sep 2024, 20 months.

Results were first posted in Dec 2025, 1 year 2 months after primary completion.

Of 457 non-industry interventional studies with no phase under Stress, Psychological, half reached primary completion within 13 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 26. This study's 20 months is above that.

Counting every sponsor, half of 470 studies reached it within 13 months; a quarter within 5 and three quarters within 26.

How these figures are worked out, and which studies are left out of them.

Registered
Jun 13, 2022
First posted
Jun 16, 2022
StartActual
Jan 2, 2023
Primary completionActual
Sep 30, 2024
CompletionActual
Dec 31, 2024
Results first posted
Dec 29, 2025
Last update
Dec 29, 2025
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Dec 29, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05422638
Responsible party
Sponsor
First posted
Jun 16, 2022
Start date
Jan 2, 2023
Primary completion
Sep 30, 2024
Completion
Dec 31, 2024
Results posted
Dec 29, 2025
Last update
Dec 29, 2025

Study contacts

Ariel J. Lang, PhD
principal investigator · VA San Diego Healthcare System, San Diego, CA

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion